NorthWest Biotherapeutics Inc (NWBO)

[longusa]

Re Market Cap, some context

So, in the big leagues, we have:
- Roche: ~250B
- Novartis: ~250B
- Gilead: ~150B
- BMY: ~75B

In the 'up and comer' category of companies in the past few years showing data of efficacy:
- Jazz: ~9B
- PCYC: ~9B
- ICPT: ~6B
- ONYX: M&A for ~9B if I remember right

So, if DCVax-L shows efficacy in GBM, and by implication, for all solid tumor cancers, what might we see? Seems 6B - 9B would be rational after the implication sinks in. Given the mkt caps substantially above that for the BPs, an M&A several multiples above would also be rational.

For pps, use 90m - 100m shares outstanding = current outstanding shares + warrants + a few more cap raises.

I'm not saying the above is guaranteed, just the reason why I am invested. As Smith says, a good asymmetric investment.